AktiVax is a Colorado medical device company developing prefilled drug delivery systems, addressing many of the shortfalls of conventional vials and syringes. The company is looking to become a leading global supplier of solutions and products to the pharmaceutical industry and capture a portion of the >$7B primary container market. AktiVax is currently developing novel reconstitution, safety syringes for vaccines and biologics. AktiVaxâs solution involves a three-pillared approach: expertise in cost-effective, dry vaccine formulation; differentiated delivery devices; and efficient manufacturing for rapid market distribution
